Cancer clinical trials in the region Bourgogne-Franche-Comté
210 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Pancreas cancer
#NCT05065801
Adenocarcinoma
Metastatic
Systemic Treatment-Naive
Surgery
Chemotherapy
Radiotherapy
Radiochemotherapy
Institut Godinot (Reims), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier de Perpignan (Perpignan), Institut du cancer de Montpellier (Montpellier)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
Pancreas cancer
#NCT06119217
Adenocarcinoma
Metastatic
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Lille (Lille), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
Trishula Thérapeutique, Inc.
Phase 2
Lung cancer
#NCT03915678
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Immunotherapy
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Oscar Lambret (Lille) (and 4 more...)
Institut Bergonié
Phase 2
Colon cancer
Rectal cancer
#NCT04420884
Adenocarcinoma
Locally Advanced
Metastatic
MSI/dMMR
MSS
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Besançon (Besançon), Centre Léon Bérard (Lyon), Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), Centre François Baclesse (Caen ), Hôpital de la Timone AP-HM (Marseille) (and 7 more...)
Takeda
Phase 2
Kidney cancer
#NCT06099782
Surgery
Grade 3
Grade 4
Immunotherapy
Bispecific T-cell engager antibodies
Radiotherapy
Centre Léon Bérard (Lyon), CHU Caen Normandie (Caen), Clinique Chénieux (Limoges), Hôpital Bichat - Claude Bernard - AP-HP (Paris), Hôpital d'Instruction des Armées Sainte-Anne (Toulon)
Merck Sharp & Dohme LLC
Phase 2
Lung cancer
#NCT06099782
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Systemic Treatment-Naive
PDL1 Positive (>= 50%)
Immunotherapy
Immunotherapy
Bispecific T-cell engager antibodies
Centre Léon Bérard (Lyon), CHU Caen Normandie (Caen), Clinique Chénieux (Limoges), Hôpital Bichat - Claude Bernard - AP-HP (Paris), Hôpital d'Instruction des Armées Sainte-Anne (Toulon)
Merck Sharp & Dohme LLC
Phase 2
Lung cancer
#NCT05967689
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), CHU Caen Normandie (Caen), Institut Curie - Paris (Paris), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Universitaire Laennec (Saint-Herblain) (and 4 more...)
Taiho Oncology
Phase 2
Breast cancer
#NCT05955170
HER2 Positive
Metastatic
Chemotherapy
Targeted therapy
Chemotherapy
Targeted therapy
Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud), Institut Sainte Catherine (Avignon), Hôpital Privé du Confluent - Vivalto Santé (Nantes)
Institut Curie
Phase 2
Rectal cancer
#NCT05723562
Locally Advanced
MSI/dMMR
Systemic Treatment-Naive
MSS
Surgery
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Radiotherapy
Centre Hospitalier Universitaire de Besançon (Besançon), Institut Paoli-Calmettes (Marseille), CHU de Rennes - Hôpital Pontchaillou (Rennes), CHU - Haut-lévêque - Bordeaux (Pessac), Hôpital Saint Antoine AP-HP (Paris)
GlaxoSmithKline
Phase 2
Colon cancer
Rectal cancer
#NCT05706779
Adenocarcinoma
Localized
BRAF
Systemic Treatment-Naive
KRAS G12C
KRAS non G12C
NRAS
Targeted therapy
Hôpital Européen Georges Pompidou - AP-HP (Paris), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon)
Fédération Francophone de Cancérologie Digestive